Retinai

BSI has certified our platform RetinAI Discovery and 3 of our #AI models under the Medical Devices Regulation EU 2017/745! This certification underscores our commitment to excellence and compliance with the highest industry standards. What this means:  👉 Our quality management system met the rigorous requirements of the EU Medical Device Regulation (EU) 2017/745, ensuring top-tier safety and effectiveness. 👉 Our advanced ophthalmology assessment and diagnostic support technologies, including RetinAI's AI models for Macula Biomarkers, Layer Segmentation and Fluid Segmentation models, have been validated and recognized to meet a healthcare need. 👉 With this certification, we strengthen our position as a trusted pioneer in the AI healthcare technology space. This milestone is a testament to our team's dedication and the robust quality systems we have in place. Thank you to our team, partners, and clients for their unwavering support. Together, we are shaping the future of eye care! For more information, read the press release 👉 https://lnkd.in/ecsjmHQW #MDRCertification #AIinHealthcare #Innovation #QualityAssurance #HealthcareTech Ikerian

🗓 Save the Date: December 17th Join us for our upcoming webinar as we explore the achievements, innovations, and real-world clinical benefits of RetinAI Discovery®. We are honored to host esteemed experts, Prof. Paulo Eduardo Stanga and Dr. Francisco Cabrera López, who will share their insights and experiences. What to Expect: 1️⃣ Highlights of RetinAI’s 2024 achievements 2️⃣ A sneak peek at exciting new features to RetinAI Discovery, including: - Automated data uploads to simplify data management - Our AI-powered SEARCH engine for faster patient identification based on biomarker criteria - SMART Alarm Notifications to flag key patient characteristics for efficient monitoring 3️⃣ Real-world insights from physicians using RetinAI Discovery® Join us to see how RetinAI Discovery® is transforming retinal disease management with cutting-edge tools for OCT analysis, fluid tracking, and multimodal data integration. Register now 👉 https://lnkd.in/eQvcsP_D

Ready to transform your clinical & research workflows with AI-powered volumetric measures? Today's the day, join our webinar at 7PM CET (1PM EST) to know more! Here’s why RetinAI Discovery is your best choice: ✅ Make more informed decisions working with a multimodality data platform ✅ Provide your patients with advanced, comprehensive assessments where they can see progress ✅ Save time while increasing accuracy with advanced layer and fluid segmentations and ✅ Set best practices in your clinic looking at retrospective data using AI to support your decisions Join Dr. Rosa Dolz Marco, renowned #Retina specialist from the Oftalvist Clinic in Valencia, Spain, today at 7 PM CET (1 PM EST) for a live webinar! She’ll dive into real case studies (nAMD and GA) to show how AI-powered volumetric measures enhance patient subgroup analysis and improve insights on disease outcomes. Don't miss out, find our more and register for free here 👉 https://lnkd.in/eM6CwnyE

We are looking for a Medical Data Scientist / Statistician to join our team! Check our the job description below and apply today ✨

At RetinAI, we’re committed to helping providers make the right decisions, sooner. This week, our CEO Carlos Ciller is featured in the Ophthalmology Innovation Source Weekly newsletter, sharing our mission and strategic vision to transform patient care through #AI-driven innovation. 🎥 Watch the video from OIS Retina 2024 to learn more about our journey: https://lnkd.in/e6JgfGXu Join us in continuing the conversation during OIS XIV today, book a meeting with Jonathan Sourris here: https://lnkd.in/eF4PezfQ Let’s work together to break barriers and shape the future of healthcare! #OISXIV #OISWeekly #RetinAI #AIinHealthcare #InnovationInOphthalmology #PatientCare

Could AI be the answer to support management of the growing challenge of Age-related Macular Degeneration (AMD)? In this on-demand webinar, Dr. Aude Ambresin explores how integrating AI can optimize three critical aspects of AMD management: 1️⃣ Enhancing the patient journey, streamlining personalized care pathways 2️⃣ Advancing imaging analysis with automated segmentation of retinal layers and fluid volumes using RetinAI Discovery® 3️⃣ Accelerating Clinical Research by delivering faster insights and better decision-making in AMD and Geographic Atrophy (GA) studies The session wraps up with a practical Q&A session, offering deeper insights and real-world examples from the audience. Watch the full presentation now 👉 https://lnkd.in/eKkG5SMq #Ophthalmology #AMDManagement #AIinHealthcare #RetinalImaging #ClinicalResearch #RetinAI

We are thrilled to be part of Ophthalmology Innovation Source XIV in San Diego on November 22 and 23! Jonathan Sourris, our Business Development Manager, will be on-site to connect with leaders in ophthalmic innovation and share how RetinAI Discovery is advancing clinical trial conduct and enriching real-world datasets through AI-powered imaging analysis. Our solutions empower Pharma, Clinics, and Research to generate insights that enhance and improve patient care and accelerate breakthroughs in ophthalmology and digital health. 📅 Want to discuss how we can support your R&D and clinical study initiatives? Schedule a one-on-one meeting with Jonathan here: https://lnkd.in/eF4PezfQ We’re looking forward to connecting and sharing our vision for AI in eye care. See you at OIS XIV on November 22-23!

Our latest abstract, published in the Association for Research in Vision and Ophthalmology (ARVO) IOVS Journal (June 2024), reveals a correlation between OCT and FAF measurements for GA lesions, with RPE and PR loss serving as reliable biomarkers for assessing GA. With our advanced OCT segmentation model in Research Use Only, physicians can now automatically detect and measure RPE and PR loss, making pre-screening and screening in clinical trials faster and more precise. Read the full abstract on our website, and see how we are redefining retinal imaging and analysis 👉 https://lnkd.in/eHcpRJmt

We are looking for you to join our team! Check out the roles and apply today 👇

Learn how to use AI to accelerate your research analysis and clinical workflows together with Dr. Rosa Dolz Marco on November 28th! Join our webinar to get insights on the importance and benefits of volumetric measures and AI automatic analysis to measure disease endpoints! We will be discussing different case reviews including Neovascular AMD and Geographic Atrophy! Secure your spot now to join the webinar!👇 https://lnkd.in/eM6CwnyE